Report

Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.

Asset 41 2
160 1608792 circle document icon png transparent png

Organoids Market Forecast to 2028 – Global Analysis By Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells), and Geography

The organoids market is expected to grow from US$ 2,507.28 million in 2022 to US$ 12,206.15 million in 2030; it is estimated to register a CAGR of 21.9% from 2022 to 2030.

The factors such as need for organoids post-thoracic surgery and the advantages of organoids over analog thoracic drainage devices are expected to drive the organoids market growth. Moreover, combining organoid with organ-on-a-chip is also expected to foster the organoids market growth during the forecast period. However, the lack of skilled personnel hinders the organoids market growth.

Combining Organoid with Organ-On-A-Chip to Boost the Organoids Market in Future

Organoid and organ-on-a-chip, which serve as evolving pathological and human physiological relevant in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit benefits of both organoid and organ-on-a-chip and provide a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.

In addition, technological advancements will facilitate various applications in biological and biomedical fields for disease modeling and clinical drug screening by combining organoids with organ-on-a-chip. Technological advancements have enabled the development of brain organoids-on-chip, liver organoids-on-chip, intestine organoids-on-chip, and more. Although organoid-on-a-chip is currently a developing field, much scope exists for improvement. Thus, it will also require cooperative efforts from interdisciplinary researchers to reach organoids’ full utility in human biomedical studies and lead the market’s growth in the coming future.

The global organoids market is segmented on the basis of type, application, and source. Based on type, the organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment held the largest organoids market share in 2022. However, the stomach segment is anticipated to register the highest CAGR from 2022 to 2030. Organoids developed from primary stomach tissues offer a physiological understanding of the stomach. In addition to various research studies conducted in the past, several studies are being undertaken to understand the mechanism of dysregulation of the physiological function of the gastric mucosal barrier by pathogens. In the last few decades, significant efforts have been made to understand the morphogenesis and homeostasis of the digestive system using various animal models. Based on application, the organoids market is segmented into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery & personalized medicine, and others. The developmental biology held a larger organoids market share in 2022. However, the drug discovery & personalized medicine segment is anticipated to grow with a higher CAGR from 2022 to 2030. The need to improve R&D productivity can be attributed to high attrition levels during the drug development process. ~90% of drugs tested for anticancer activities in clinical trials fail to meet their primary endpoints. New approaches to drug screening are being developed, which focus on biomimetic platforms. Organoids for testing personalized medicines are derived from embryonic stem cells and adult stem cells. Therefore, they create the functional mini manifestation of the parent organ. As personalized medicine entirely relies on matching individualized responses with potential treatments, it is widely preferred as a molecular approach to cancer therapy. Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells held the largest market in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030. The three primary groups of cells formed by the pluripotent cells make up a human body. These cells can be potentially used in cell replacement therapy to treat patients with cellular diseases. Thus, they are widely used for developing an organoid in vitro. In addition, pluripotent cells are used in biobanking to preserve patient-derived stem cells in various applications, which can be used in research and therapeutics.

National Research Foundation (NRF), Spanish National Transplant Organization, Organization for Economic Co-operation and Development (OECD), and the Research, Innovation and Dissemination Centers (RIDCs) are among some of the primary and secondary sources referred to while preparing the report on the organoids market.

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Organoids Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
5. Organoids Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Demand for Tumor Modeling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Key Market Restraints:
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Key Market Opportunities:
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends:
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis:
6. Organoids Market – Global Market Analysis
6.1 Organoids Market Revenue (US$ Mn), 2028 – 2030
7. Global Organoids Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Organoids Market Revenue Share, by Type 2028 & 2030 (%)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Organoids Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Organoids Market Revenue Share, by Application 2028 & 2030 (%)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Organoids Market – Revenue and Forecast to 2030 – by Source
9.1 Overview
9.2 Organoids Market Revenue Share, by Source 2028 & 2030 (%)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10. Organoids Market – Geographical Analysis
10.1 North America Organoids Market, Revenue And Forecast to 2030
10.1.1 Overview
10.1.2 North America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America Organoids Market, by Type
10.1.4 North America Organoids Market, by Application
10.1.5 North America Organoids Market, by Source
10.1.6 North America Organoids Market, by Country
10.1.6.1 US
10.1.6.1.1 Overview
10.1.6.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.3 US Organoids Market, by Type
10.1.6.1.4 US Organoids Market, by Application
10.1.6.1.5 US Organoids Market, by Source
10.1.6.2 Canada
10.1.6.2.1 Overview
10.1.6.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) 65
10.1.6.2.3 Canada Organoids Market, by Type
10.1.6.2.4 Canada Organoids Market, by Application
10.1.6.2.5 Canada Organoids Market, by Source
10.1.6.3 Mexico
10.1.6.3.1 Overview
10.1.6.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.3 Mexico Organoids Market, by Type
10.1.6.3.4 Mexico Organoids Market, by Application
10.1.6.3.5 Mexico Organoids Market, by Source
10.2 Europe Organoids Market, Revenue And Forecast to 2030
10.2.1 Overview
10.2.2 Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe Organoids Market, by Type
10.2.4 Europe Organoids Market, by Application
10.2.5 Europe Organoids Market, by Source
10.2.6 Europe Organoids Market by Country
10.2.6.1 Germany
10.2.6.1.1 Overview
10.2.6.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.3 Germany Organoids Market, by Type
10.2.6.1.4 Germany Organoids Market, by Application
10.2.6.1.5 Germany Organoids Market, by Source
10.2.6.2 UK
10.2.6.2.1 Overview
10.2.6.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.3 UK Organoids Market, by Type
10.2.6.2.4 UK Organoids Market, by Application
10.2.6.2.5 UK Organoids Market, by Source
10.2.6.3 France
10.2.6.3.1 Overview
10.2.6.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.3 France Organoids Market, by Type
10.2.6.3.4 France Organoids Market, by Application
10.2.6.3.5 France Organoids Market, by Source
10.2.6.4 Italy
10.2.6.4.1 Overview
10.2.6.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.3 Italy Organoids Market, by Type
10.2.6.4.4 Italy Organoids Market, by Application
10.2.6.4.5 Italy Organoids Market, by Source
10.2.6.5 Spain
10.2.6.5.1 Overview
10.2.6.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.3 Spain Organoids Market, by Type
10.2.6.5.4 Spain Organoids Market, by Application
10.2.6.5.5 Spain Organoids Market, by Source
10.2.6.6 Rest of Europe
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.3 Rest of Europe Organoids Market, by Type
10.2.6.6.4 Rest of Europe Organoids Market, by Application
10.2.6.6.5 Rest of Europe Organoids Market, by Source
10.3 Asia Pacific Organoids Market, Revenue And Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific Organoids Market, by Type
10.3.4 Asia Pacific Organoids Market, by Application
10.3.5 Asia Pacific Organoids Market, by Source
10.3.6 Asia Pacific Organoids Market by Country
10.3.6.1 China
10.3.6.1.1 Overview
10.3.6.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.3 China Organoids Market, by Type
10.3.6.1.4 China Organoids Market, by Application
10.3.6.1.5 China Organoids Market, by Source
10.3.6.2 Japan
10.3.6.2.1 Overview
10.3.6.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.3 Japan Organoids Market, by Type
10.3.6.2.4 Japan Organoids Market, by Application
10.3.6.2.5 Japan Organoids Market, by Source
10.3.6.3 India
10.3.6.3.1 Overview
10.3.6.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.3 India Organoids Market, by Type
10.3.6.3.4 India Organoids Market, by Application
10.3.6.3.5 India Organoids Market, by Source
10.3.6.4 Australia
10.3.6.4.1 Overview
10.3.6.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.3 Australia Organoids Market, by Type
10.3.6.4.4 Australia Organoids Market, by Application
10.3.6.4.5 Australia Organoids Market, by Source
10.3.6.5 South Korea
10.3.6.5.1 Overview
10.3.6.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.3 South Korea Organoids Market, by Product Type
10.3.6.5.4 South Korea Organoids Market, by Application
10.3.6.5.5 South Korea Organoids Market, by Source
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.3 Rest of Asia Pacific Organoids Market, by Type
10.3.6.6.4 Rest of Asia Pacific Organoids Market, by Application
10.3.6.6.5 Rest of Asia Pacific Organoids Market, by Source
10.4 Middle East & Africa Organoids Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa Organoids Market, by Type
10.4.4 Middle East & Africa Organoids Market, by Application
10.4.5 Middle East & Africa Organoids Market, by Source
10.4.6 Middle East & Africa Organoids Market by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.3 Saudi Arabia Organoids Market, by Type
10.4.6.1.4 Saudi Arabia Organoids Market, by Application
10.4.6.1.5 Saudi Arabia Organoids Market, by Source
10.4.6.2 UAE
10.4.6.2.1 Overview
10.4.6.2.2 UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.3 UAE Organoids Market, by Type
10.4.6.2.4 UAE Organoids Market, by Application
10.4.6.2.5 UAE Organoids Market, by Source
10.4.6.3 South Africa
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.3 South Africa Organoids Market, by Type
10.4.6.3.4 South Africa Organoids Market, by Application
10.4.6.3.5 South Africa Organoids Market, by Source
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.3 Rest of Middle East & Africa Organoids Market, by Type
10.4.6.4.4 Rest of Middle East & Africa Organoids Market, by Application
10.4.6.4.5 Rest of Middle East & Africa Organoids Market, by Source
10.5 South & Central America Organoids Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America Organoids Market, by Type
10.5.4 South & Central America Organoids Market, by Application
10.5.5 South & Central America Organoids Market, by Source
10.5.6 South & Central America Organoids Market by Country
10.5.6.1 Brazil
10.5.6.1.1 Overview
10.5.6.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.3 Brazil Organoids Market, by Type
10.5.6.1.4 Brazil Organoids Market, by Application
10.5.6.1.5 Brazil Organoids Market, by Source
10.5.6.2 Argentina
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.3 Argentina Organoids Market, by Type
10.5.6.2.4 Argentina Organoids Market, by Application
10.5.6.2.5 Argentina Organoids Market, by Source
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.3 Rest of South & Central America Organoids Market, by Type
10.5.6.3.4 Rest of South & Central America Organoids Market, by Application
10.5.6.3.5 Rest of South & Central America Organoids Market, by Source
11. Pre & Post Covid-19 Impact
11.1 Pre & Post Covid-19 Impact
12. Organoids Market Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Organoids Market, Key Company Profiles
13.1 STEMCELL Technologies Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Cellesce Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Definigen
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Organoid Therapeutics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 3Dnamics Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Thermo Fisher Scientific Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Corning Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Merck KGaA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 InSphero
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Organoids Market Segmentation
Table 2. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 3. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 4. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 5. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 6. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 7. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 8. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type 65
Table 9. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 10. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 11. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 12. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 13. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 14. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 15. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 16. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 17. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 18. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 19. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 20. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 21. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 22. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 23. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 24. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 25. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 26. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 27. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 28. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 29. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 30. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 31. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 32. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 33. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 34. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 35. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 36. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 37. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 38. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 39. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 40. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 41. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 42. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 43. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 44. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 45. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 46. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 47. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Type
Table 48. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 49. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 50. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 51. South Korea Organoids Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 52. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 53. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) –Type
Table 54. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 55. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) Source
Table 56. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 57. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 58. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 59. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 60. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 61. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 62. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 63. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 64. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 65. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 66. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 67. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 68. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 69. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 70. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 71. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 72. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 73. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 74. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 75. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 76. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 76. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 77. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 78. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 79. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Type
Table 80. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 81. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) – Source
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done by Companies
Table 84. Glossary of Terms, Organoids Market

LIST OF FIGURES

Figure 1. Organoids Market Segmentation, By Geography
Figure 2. North America – PEST Analysis
Figure 3. Europe – PEST Analysis
Figure 4. Asia Pacific – PEST Analysis
Figure 5. South & Central America – PEST Analysis
Figure 6. Middle East & Africa – PEST Analysis
Figure 7. Organoids Market – Key Industry Dynamics
Figure 8. Impact Analysis of Drivers and Restraints
Figure 9. Organoids Market Revenue (US$ Mn), 2028 – 2030
Figure 10. Organoids Market Revenue Share, by Type 2028 & 2030 (%)
Figure 11. Stomach: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Intestine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Liver: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Pancreas: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Lung: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Brain: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Kidney: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Organoids Market Revenue Share, by Application 2028 & 2030 (%)
Figure 20. Developmental Biology: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21 . Disease Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Regenerative Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Organoids Market Revenue Share, by Source 2028 & 2030 (%)
Figure 27. Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Organoids Market, 2030 ($Mn)
Figure 30. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 31. North America Organoids Market, By Key Countries, 2028 And 2030 (%)
Figure 32. US Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 33. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) 65
Figure 34. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Europe Organoids Market, By Geography, 2030 ($Mn)
Figure 36. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Europe Organoids Market, By Key Countries, 2028 And 2030 (%)
Figure 38. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 39. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 40. France Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 41. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 42. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 43. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. Organoids Market, By Geography, 2030 ($Mn)
Figure 45. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. Asia Pacific Organoids Market, By Key Countries, 2028 And 2030 (%)
Figure 47. China Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 48. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 49. India Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 50. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn)
Figure 51. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. Organoids Market, By Geography, 2028 And 2030 ($Mn)
Figure 54. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Middle East & Africa Organoids Market, By Key Countries, 2028 And 2030 (%)
Figure 56. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Organoids Market, By Geography, 2030 ($Mn)
Figure 61. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 62. South & Central America Organoids Market, By Key Countries, 2028 And 2030 (%)
Figure 63. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 64. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 65. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
Figure 66. Pre & Post Covid-19 Impact
Figure 67. Growth Strategies Done by the Companies in the Market, (%)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the organoids market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in the global organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth global market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

The List of Companies – Organoids Market
● STEMCELL Technologies Inc
● Cellesce Ltd
● Hubrecht Organoid Technology
● Definigen
● Organoid Therapeutics
● PeproTech, Inc
● Thermo Fisher Scientific Inc
● Corning Inc
● Merck KGaA
● InSphero.

Pricing

$4,550.00$8,550.00

Have a Query?

Have a Question?

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

GET FREE SAMPLE PDF

× Enquire Now